CMS certification 150021
Parkview Regional Medical Center
11109 Parkview Plaza Drive, Fort Wayne, IN 46845
Parkview Regional Medical Center has a CMS overall rating of 3 out of 5 stars. 79% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 2. Emergency patients spend a median of 2 h 30 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 398 completed surveys, 19% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | IN | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 390 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 30 min | 2 h 25 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 11 visits sampled | 2 h 55 min | 3 h 51 min | 4 h 17 min |
| Left before being seen Lower is better · 154,253 patients | 1% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 96 patients | 59% | 60% | 65% |
How Parkview Regional Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Parkview Regional Medical CenterThis hospital | 3/5 | 79% | 2 h 30 min | 5 better 2 worse |
| Orthopaedic Hospital at Parkview NorthSame city | Not rated | 80% | — | 1 better |
| Dupont Hospital LLCSame city | 4/5 | 69% | 2 h 6 min | 1 better 2 worse |
| Lutheran Hospital of IndianaSame city | 3/5 | 58% | 3 h 35 min | 3 better 1 worse |
| St Joseph Health System, LLCSame city | 4/5 | 73% | 2 h 1 min | 1 worse |
| The Orthopaedic Hospital of Lutheran Health NetworSame county · Ft Wayne | Not rated | 69% | — | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Fort Wayne.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,589 cases | Too few cases | 3.5% | 3.9% |
| Heart attack 457 cases | Too few cases | 12.4% | 11.9% |
| Heart failure 707 cases | Too few cases | 13.7% | 11.1% |
| Pneumonia 813 cases | Too few cases | 14.5% | 15.2% |
| Stroke 727 cases | Too few cases | 10.8% | 11.9% |
| COPD 204 cases | Too few cases | 9.4% | 8.6% |
| Heart bypass surgery (CABG) 131 cases | Too few cases | 2.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.9 likely 0.65 – 1.15 | 1 |
| Deaths after a serious but treatable surgical complication 182 cases | No different | 190.66 per 1,000 likely 150.86 per 1,000 – 230.47 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 11,748 cases | No different | 0.34 per 1,000 likely 0 per 1,000 – 0.8 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 13,792 cases | No different | 0.15 per 1,000 likely 0 per 1,000 – 0.33 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 14,274 cases | No different | 0.24 per 1,000 likely 0.06 per 1,000 – 0.41 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,103 cases | No different | 1.71 per 1,000 likely 0.47 per 1,000 – 2.95 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 962 cases | No different | 1.15 per 1,000 likely 0 per 1,000 – 2.59 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 915 cases | No different | 9.46 per 1,000 likely 4.04 per 1,000 – 14.88 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,241 cases | No different | 3.3 per 1,000 likely 1.68 per 1,000 – 4.93 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 922 cases | No different | 6.6 per 1,000 likely 3.37 per 1,000 – 9.84 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 674 cases | No different | 1.96 per 1,000 likely 0.59 per 1,000 – 3.33 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,267 cases | No different | 0.69 per 1,000 likely 0 per 1,000 – 1.47 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.36 likely 0.19 – 0.63 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.46 likely 0.28 – 0.74 | 1 |
| Surgical site infections after colon surgery | Better | 0.35 likely 0.13 – 0.77 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0 | 1 |
| MRSA bloodstream infections | Better | 0.25 likely 0.06 – 0.67 | 1 |
| C. diff intestinal infections | Better | 0.49 likely 0.37 – 0.64 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 889 cases | Too few cases | 13.5% | 14.4% |
| Readmitted after heart failure 1,416 cases | Too few cases | 19.1% | 21.3% |
| Readmitted after pneumonia 1,575 cases | Too few cases | 15.6% | 17.3% |
| Readmitted after COPD 445 cases | Too few cases | 19.9% | 20% |
| Readmitted after heart bypass surgery 202 cases | Too few cases | 10.3% | 11% |
| Days back in hospital after a heart attack 496 cases | Too few cases | 2.6 days per 100 | — |
| Days back in hospital after heart failure 796 cases | Too few cases | -6.5 days per 100 | — |
| Days back in hospital after pneumonia 899 cases | Too few cases | -21.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,918 cases | No different | 14.3 per 1,000 likely 11.5 per 1,000 – 17.8 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 607 cases | Worse | 14 per 100 likely 11.7 per 100 – 16.5 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 607 cases | No different | 5.6 per 100 likely 4.2 per 100 – 7.2 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,082 cases | Worse | 1.3 likely 1.1 – 1.5 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
464 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 123 |
| Pharmacist | 92 |
| Physician Assistant | 53 |
| Nurse Practitioner | 46 |
| Emergency Medicine | 27 |
| Anatomic Pathology & Clinical Pathology | 12 |
| Medical | 11 |
| Dietitian, Registered | 10 |
| Anesthesiology | 9 |
| Critical Care Medicine | 8 |
| Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist | 8 |
| Pharmacotherapy | 7 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.1M
- 2020 $1.6M
- 2021 $2M
- 2022 $2.3M
- 2023 $3M
- 2024 $2.1M
- 2025 $1.6M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $189,615 | 78 |
| Medical devices and supplies on long-term loan | $54,790 | 6 |
| Space rental and facility fees | $15,751 | 19 |
| Grants | $1,750 | 2 |
| Debt forgiveness | $181 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $944,533 | 22 |
| Insulet Corporation | $159,675 | 48 |
| Eli Lilly and Company | $92,520 | 2 |
| Abbvie INC. | $89,214 | 20 |
| AstraZeneca Pharmaceuticals LP | $88,845 | 3 |
| Medtronic, Inc. | $80,740 | 14 |
| AngioDynamics, Inc. | $42,750 | 2 |
| AstraZeneca UK Limited | $21,460 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Belzutifan MK-6482 and Lenvatini… Merck Sharp & Dohme LLC | $256,582 |
| A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizu… Merck Sharp & Dohme LLC | $184,662 |
| A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy ,- Pembrolizumab MK-3475 as Neoadjuvant,Adjuvant Therapy for Participant… Merck Sharp & Dohme LLC | $103,499 |
| A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab MK-3475 Versus Trea… Merck Sharp & Dohme LLC | $99,793 |
| SUNRAY-01 A GLOBAL PIVOTAL STUDY IN PARTICIPANTS WITH KRAS G12C-MUTANT LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER COMPARING FIRST LINE… Eli Lilly and Company · NCT06119581 | $92,520 |
| A Phase 3, Randomized Double Blind Study to Evaluate Peri-operative Pembrolizumab MK-3475 Neoadjuvant Chemotherapy versus Perioperative Placebo Neo… Merck Sharp & Dohme LLC | $81,377 |
| A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not… Merck Sharp & Dohme LLC | $77,804 |
| A Phase III, Open-label, Randomized Study of Osimertinib with or without Datopotamab deruxtecan (Dato-DXd), as First-line Treatment in Patients with … AstraZeneca Pharmaceuticals LP | $60,184 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Parkview Regional Medical Center
Is Parkview Regional Medical Center a good hospital?
Parkview Regional Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Parkview Regional Medical Center?
79% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 398 completed HCAHPS surveys.
How long is the wait in the Parkview Regional Medical Center emergency room?
Emergency patients spend a median of 2 h 30 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Parkview Regional Medical Center receive money from drug and device companies?
Drug and device makers reported $1.6M in payments to Parkview Regional Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.